Sulfonamidomethyl phosphonate inhibitors of beta-lactamase
US6472406B1 · kind B1 · utility
8Cited by
6References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 5, 2000 |
| Grant date | Oct 29, 2002 |
| Priority date | — |
| Expiry date | Jul 5, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/655345
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The intention relates to bacterial antibiotic resistance and, in particular, to compositions and methods for overcoming bacterial antibiotic resistance. The invention provides novel &bgr;-lactamase inhibitors, which are structurally unrelated to the natural product and semi-synthetic &bgr;-lactamase inhibitors presently available, and which do not require a &bgr;-lactam pharmacophore. The invention also provides pharmaceutical compositions and methods for inhibiting bacterial growth.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.